scholarly article | Q13442814 |
P356 | DOI | 10.3233/BME-171624 |
P698 | PubMed publication ID | 28372278 |
P2093 | author name string | L Zhang | |
N de Isla | |||
Y P Li | |||
Y Y Li | |||
L Targa | |||
J F Stoltz | |||
H Z Han | |||
J S Ye | |||
N Charif | |||
P2860 | cites work | Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells | Q46286017 |
Effect of donor age on the growth in vitro of cells obtained from human trabecular bone | Q47578048 | ||
mTert expression correlates with telomerase activity during the differentiation of murine embryonic stem cells. | Q47823442 | ||
Patients with primary osteoarthritis show no change with ageing in the number of osteogenic precursors. | Q50852537 | ||
Skeletal progenitor cells and ageing human populations. | Q50873506 | ||
Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells. | Q52119168 | ||
Oxidative stress induces senescence in human mesenchymal stem cells. | Q54384642 | ||
Upregulation of p16INK4A promotes cellular senescence of bone marrow-derived mesenchymal stem cells from systemic lupus erythematosus patients. | Q54495613 | ||
Stem Cells and Regenerative Medicine: Myth or Reality of the 21th Century | Q26795447 | ||
Aging: a theory based on free radical and radiation chemistry | Q27860549 | ||
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement | Q27861120 | ||
In vitro high-capacity assay to quantify the clonal heterogeneity in trilineage potential of mesenchymal stem cells reveals a complex hierarchy of lineage commitment | Q28272235 | ||
Lack of telomerase activity in human mesenchymal stem cells | Q30164727 | ||
Replicative senescence of mesenchymal stem cells: a continuous and organized process | Q33336408 | ||
Aging and replicative senescence have related effects on human stem and progenitor cells | Q33464937 | ||
Long term culture of mesenchymal stem cells in hypoxia promotes a genetic program maintaining their undifferentiated and multipotent status | Q33857675 | ||
How to track cellular aging of mesenchymal stromal cells? | Q33896770 | ||
Reduced reactivation from dormancy but maintained lineage choice of human mesenchymal stem cells with donor age. | Q33995621 | ||
Telomere length, stem cells and aging | Q34689235 | ||
Age-related changes in human bone marrow-derived mesenchymal stem cells: consequences for cell therapies | Q34744250 | ||
Phenotype, donor age and gender affect function of human bone marrow-derived mesenchymal stromal cells | Q34768188 | ||
The composition of the mesenchymal stromal cell compartment in human bone marrow changes during development and aging | Q35717741 | ||
Aging of mesenchymal stem cells | Q36323407 | ||
Age-related intrinsic changes in human bone-marrow-derived mesenchymal stem cells and their differentiation to osteoblasts | Q36681378 | ||
Hypoxic culture conditions for Mesenchymal Stromal/Stem Cells from Wharton's jelly: a critical parameter to consider in a therapeutic context | Q39024220 | ||
Human mesenchymal stem cells efficiently manage oxidative stress | Q39716782 | ||
Downregulation of APE1/Ref-1 is involved in the senescence of mesenchymal stem cells. | Q39843440 | ||
Expansion of human adult stem cells from bone marrow stroma: conditions that maximize the yields of early progenitors and evaluate their quality | Q45856815 | ||
Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate | Q45863683 | ||
Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion | Q45877573 | ||
P433 | issue | s1 | |
P921 | main subject | regenerative medicine | Q1061415 |
P304 | page(s) | S57-S63 | |
P577 | publication date | 2017-01-01 | |
P1433 | published in | Bio-Medical Materials and Engineering | Q15746681 |
P1476 | title | Aging of bone marrow mesenchymal stromal/stem cells: Implications on autologous regenerative medicine | |
P478 | volume | 28 |
Q89447778 | Bone marrow mesenchymal stem cells: Aging and tissue engineering applications to enhance bone healing |
Q47643280 | Low-intensity pulsed ultrasound activates ERK1/2 and PI3K-Akt signalling pathways and promotes the proliferation of human amnion-derived mesenchymal stem cells. |
Q90181998 | Mesenchymal Stem Cell Derived Extracellular Vesicles in Aging |
Q52698412 | Mesenchymal Stem Cells as New Therapeutic Agents for the Treatment of Primary Biliary Cholangitis. |
Q91893537 | Potential biological therapies for severe preeclampsia: a systematic review and meta-analysis |
Q92351043 | Potential of mesenchymal- and cardiac progenitor cells for therapeutic targeting of B-cells and antibody responses in end-stage heart failure |
Q54112596 | Reactive Oxygen Species, Superoxide Dimutases, and PTEN-p53-AKT-MDM2 Signaling Loop Network in Mesenchymal Stem/Stromal Cells Regulation. |
Q55560176 | Suppression of T cells by mesenchymal and cardiac progenitor cells is partly mediated via extracellular vesicles. |
Search more.